SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-019504
Filing Date
2024-04-12
Accepted
2024-04-12 07:16:19
Documents
5
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024347x1_def14a.htm DEF 14A 494914
2 logo_werewolf.jpg GRAPHIC 49412
3 sig_djhicklin.jpg GRAPHIC 16786
4 ny20024347x1_pc01.jpg GRAPHIC 593089
5 ny20024347x1_pc02.jpg GRAPHIC 445178
  Complete submission text file 0001140361-24-019504.txt   2016023
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40366 | Film No.: 24839967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)